Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Consulting agrmnt
Director departure
Inv. presentation
Notes underwriting agrmnt
Cord Blood America, Inc. (CBAI) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/23/2020 8-K Quarterly results
06/26/2020 8-K Quarterly results
06/16/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "CBA FLORIDA, INC. ANNOUNCES INITIAL CASH LIQUIDATING DISTRIBUTION $0.0062 per share to be paid on or about June 30, 2020 LAS VEGAS, NV / ACCESSWIRE / June 16, 2020 / CBA Florida, Inc. today announced that its Board of Directors has approved an initial liquidating cash distribution of $0.0062 per share. The distribution will be paid on or about June 30, 2020. The Board has fixed the close of business on June 26, 2020 as the record date for determining shareholders entitled to receive the initial liquidating distribution. The Company intends to file articles of dissolution with the Florida Department of State Division of Corporations on June 26, 2020, the record date for the initial liquidating distribution. In connection with the effectiveness of the articles of dissolution, CBAI will clos..."
06/02/2020 8-K Submission of Matters to a Vote of Security Holders
02/13/2020 8-K Quarterly results
08/14/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "CBA Florida, Inc. Provides 2018 Second Quarter Update LAS VEGAS, NV / ACCESSWIRE / August 14, 2018 / CBA Florida, Inc. today announced an update for the second quarter ended June 30, 2018. Highlights Include: ● The Company completed its previously announced sale of assets to California Cryobank Stem Cell Services LLC on May 17, 2018. ● The Company is discontinuing the issuance of earnings releases given it has no continuing business operations, but the Company will continue to make required filings with the Securities and Exchange Commission including its Form 10-Q for the quarter ended June 30, 2018 which will be filed today. Commentary Chairman David Sandberg stated, "After consultation with external accounting and legal advisors, the Board has determined to wait until 201..."
05/31/2018 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Articles of Amendment to Articles of Incorporation"
05/29/2018 8-K Submission of Matters to a Vote of Security Holders
05/25/2018 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Articles of Amendment to Articles of Incorporation"
05/17/2018 8-K Completion of Acquisition or Disposition of Assets, Departure of Directors or Certain Officers; Election of Directors; Appoin...
Docs: "Articles of Amendment to Articles of Incorporation of Cord Blood America, Inc",
"Investor Contact:"
05/15/2018 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Investor Contact:"
05/14/2018 8-K Quarterly results
Docs: "Cord Blood America, Inc. Reports 2018 First Quarter Results May 14, 2018 - Cord Blood America, Inc. today announced financial results for the first quarter ended March 31, 2018. Given the agreement entered into with California Cryobank Stem Cell Services LLC to sell substantially all of the Company’s assets, the operating results associated with the assets being sold have been reclassified into discontinued operations and the assets and liabilities are reflected as held-for-sale. Additional disclosure pertaining to this financial treatment is included in the Company’s 10-Q which is being filed today. Highlights Include: ● Total revenue from discontinued operations for the first quarter 2018 was $0.70 million, a decrease of 5.8% from total revenue of $0.75 million for the first quar..."
04/26/2018 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Amendments to Articles of I...
Docs: "Articles of Amendment to Articles of Incorporation of Cord Blood America, Inc. Designating Series A Preferred Stock",
"Tax Benefits Preservation Plan, by and between Cord Blood America, Inc. and Issuer Direct Corporation, as rights agent",
"Investor Contact:"
04/02/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2017 April 2, 2018 - Cord Blood America, Inc. today announced financial results for fiscal year 2017. Given the agreement entered into with California Cryobank Stem Cell Services LLC to sell substantially all of the Company’s assets for a purchase price of $15.5 million, the operating results associated with the assets being sold have been reclassified into discontinued operations and the assets and liabilities are reflected as held-for-sale. Additional disclosure pertaining to this financial treatment is included in the Company’s 10-K which is being filed today. Highlights Include: ● Total revenue from discontinued operations for the fourth quarter 2017 was $0.75 million, an increase of 2.8% from total..."
02/08/2018 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Asset Purchase Agreement by and between California Cryobank Stem Cell Services LLC and Cord Blood America, Inc., (Exhibits and schedules omitted pursuant to Item 601(b)(2) of Regulation S-K. Cord Blood America, Inc. agrees to furnish a supplemental copy of an omitted exhibit or schedule to the SEC upon request)",
"Voting Agreement, by and among California Cryobank Stem Cell Services LLC, Cord Blood America, Inc., Red Oak Fund, LP, The Red Oak Long Fund, LP and Pinnacle Opportunities Fund, LP",
"Cord Blood America, Inc. Announces Agreement to Sell Substantially All of Its Assets to FamilyCord February 7, 2018 - Cord Blood America, Inc. announced today that it has entered into an agreement with California Cryobank Stem Cell Services LLC for the sale of substantially all of its assets to FamilyCord for a purchase price of $15.5 million. Completion of the sale is contingent upon approval by CBAI’ s shareholders, receipt of certain third-party consents, and customary closing conditions for transactions of this type, as well as FamilyCord’ s obtaining external financing. The sale does not include the Company’ s cash and certain other excluded assets. CBAI plans to seek shareholder approval of the proposed sale at a special meeting of shareholders. Red Oak Partners, LLC and its affilia..."
11/13/2017 8-K Quarterly results
Docs: "Cord Blood America Reports 2017 Third Quarter Results November 13, 2017 - Cord Blood America, Inc. today announced financial results for the third quarter ended September 30, 2017. Third Quarter Highlights Include: ● Total revenue for the third quarter was $0.75 million, a decrease of 3.5% from total revenue of $0.78 million for the third quarter 2016. ● Recurring storage revenue for the third quarter 2017 was $0.67 million, a decrease of 2.4% from recurring storage revenue of $0.69 million for the third quarter 2016. ● EBITDA for the third quarter 2017 was $0.24 million, an increase of 26.7% from EBITDA of $0.19 million for the third quarter 2016. Results of Operations for the Three-Months Ended September 30, 2017 For the three months ended September 30, 2017, total ..."
08/11/2017 8-K Quarterly results
07/20/2017 8-K Form 8-K - Current report:
07/11/2017 8-K Form 8-K - Current report:
05/15/2017 8-K Form 8-K - Current report
03/28/2017 8-K Form 8-K - Current report
03/20/2017 8-K Form 8-K - Current report
11/14/2016 8-K Form 8-K - Current report
08/12/2016 8-K Form 8-K - Current report
05/16/2016 8-K Form 8-K - Current report
03/30/2016 8-K Quarterly results
Docs: "Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2015 March 30, 2016 - Cord Blood America, Inc. today announced financial results for the fourth quarter and fiscal year 2015. Highlights Include: ● Total revenue for the fourth quarter 2015 was $1.13 million, a decrease of 5.1% from total revenue of $1.20 million for the fourth quarter 2014. Total revenue for the year ended December 31, 2015 was $5.26 million, an increase of 21.3% from total revenue of $4.33 million for the year ended December 31, 2014. ● Recurring storage revenue for the fourth quarter 2015 was $0.65 million, an increase of 1.6% from recurring storage revenue of $0.64 million for the fourth quarter 2014. Recurring storage revenue for the year ended December 31, 2015 was $2.62 mill..."
02/19/2016 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Mutual Separation Agreement",
"Second Amendment to Executive Employment Agreement",
"Investor Contact: [email protected]"
12/10/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "SOURCE: Cord Blood America, Inc."
11/16/2015 8-K Quarterly results
Docs: "Cord Blood America Reports 2015 Third Quarter Financial Results Revenue increased 19%, EBITDA of $0.33 million November 16, 2015 - Cord Blood America, Inc. today announced financial results for the third quarter ended September 30, 2015. Third Quarter Highlights Include: ● Revenue increased 19.0% to $1.43 million from $1.20 million in the same period of 2014. ● Recurring revenues increased to $0.67 million and now represents over 47% of total revenue. ● EBITDA was $0.33 million compared to $0.15 million in 2014. ● Principal debt balance was reduced by 13% during the quarter with the prepayment of $175,000. Joseph Vicente, President of Cord Blood America, Inc. commented, “Our third quarter results reflect the benefit of growth on the tissue side of our business. How..."
08/13/2015 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Former Accountant’s letter to the Commission"
08/10/2015 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "ARTICLES OF AMENDMENT"
07/09/2015 8-K Other Events
05/29/2015 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "SECOND AMENDED"
05/13/2015 8-K Submission of Matters to a Vote of Security Holders
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy